Amundi
CNMD icon

Amundi’s CONMED CNMD Stock Holding History

Amundi’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Buy
9,170
+2,969
+48% +$107K ﹤0.01% 1842
2026
Q1 		$219K Buy
+6,201
New +$252K ﹤0.01% 1846
2025
Q4 		– Sell
-17,025
Closed -$791K – 1848
2025
Q3 		$791K Buy
17,025
+140
+0.8% +$7.26K ﹤0.01% 1211
2025
Q2 		$917K Sell
16,885
-8,415
-33% -$462K ﹤0.01% 1206
2025
Q1 		$1.47M Sell
25,300
-3,096
-11% -$200K ﹤0.01% 1232
2024
Q4 		$1.95M Buy
28,396
+9,303
+49% +$648K ﹤0.01% 1196
2024
Q3 		$1.23M Sell
19,093
-454
-2% -$32K ﹤0.01% 1249
2024
Q2 		$1.32M Sell
19,547
-133
-0.7% -$9.7K ﹤0.01% 1171
2024
Q1 		$1.4M Buy
19,680
+1,428
+8% +$127K ﹤0.01% 1229
2023
Q4 		$2.05M Sell
18,252
-7,078
-28% -$732K ﹤0.01% 1195
2023
Q3 		$2.37M Buy
25,330
+7,281
+40% +$837K ﹤0.01% 1138
2023
Q2 		$2.42M Buy
18,049
+11,080
+159% +$1.35M ﹤0.01% 1126
2023
Q1 		$736K Buy
6,969
+4,155
+148% +$402K ﹤0.01% 1296
2022
Q4 		$267K Sell
2,814
-23
-0.8% -$1.91K ﹤0.01% 1481
2022
Q3 		$239K Buy
+2,837
New +$268K ﹤0.01% 1436

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Amundi's CNMD Position: Q2 2026 in Review

Amundi increased its CONMED (CNMD) stake by 48% in Q2 2026, buying an estimated $107K and bringing the position to 9,170 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #1842.

Amundi first reported a position in CNMD in Q3 2022 and has held it in 15 quarters since. The position peaked at $2.42M in Q2 2023. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Amundi held 9,170 shares of CONMED worth $300K as of Q2 2026.
  • Amundi bought 2,969 CONMED shares in Q2 2026, an estimated $107K.
  • CONMED made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1842 holding.
  • Amundi first reported a position in CONMED in Q3 2022 and has held it in 15 quarters since.
  • Amundi's CONMED position peaked at $2.42M in Q2 2023.
  • 247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.